MedTrace Logo

Diclofenac add-on to Treatment as Usual for Suicidal Patients

NCT01413854 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2019-01-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether diclofenac is effective in the treatment of depressed patients with a recent suicide attempt.

Conditions

  • Depression Suicidal

Interventions

DRUG

sugar pill

One tablet two times daily during four weeks

DRUG

Diclofenac

50 mg, two times daily (oral adm.) during four weeks

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Åsa Westrin, MD, Phd · Lund University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01413854 on ClinicalTrials.gov